The use of antimycobacterial therapy in its majority leads to positive dynamics of disease, sputum conversion and tuberculosis cure. The absence of the expected positive response to the used therapy we define in a limited number of drug-susceptible tuberculosis patients. One of the most common causes of the absence of a positive response in case of provided prescription of medicines under defined and controlled sensitivity of receiving chemotherapy may be malabsorption/ maldigestion syndrome.
Citation: Kuzhko MM, Butov DO, Hulchuk NM, Avramchuk OV, Protsyk LM, et al. (2015) Clinical Case of Using Intravenous Forms of Anti-Tuberculosis Drugs to Improve the Treatment Efficiency of Tuberculosis in Patients with Malabsorption Syndrome. J Pulm Respir Med 5:269.